| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. | COO, GENERAL COUNSEL &CORP SEC | Common Stock | 32.7K | $23.5K | $0.72 | Jul 30, 2021 | Direct |
| Eloxx Pharmaceuticals, Inc. | COO, GENERAL COUNSEL &CORP SEC | Restricted Stock Units | 9.38K | $6.75K | $0.72 | Jul 30, 2021 | Direct |
| Acorda Therapeutics, Inc. | General Counsel and Corp Secy | Employee Stock Option (right to buy) | 77.3K | Mar 31, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACOR | Acorda Therapeutics, Inc. | Mar 31, 2023 | 1 | $0 | 4 | Apr 4, 2023 | General Counsel and Corp Secy |
| ACOR | ACORDA THERAPEUTICS INC | Nov 8, 2021 | 1 | $0 | 4 | Nov 9, 2021 | General Counsel |
| ACOR | ACORDA THERAPEUTICS INC | Nov 8, 2021 | 0 | $0 | 3 | Nov 9, 2021 | General Counsel |
| ELOX | Eloxx Pharmaceuticals, Inc. | Jul 30, 2021 | 3 | -$606 | 4 | Jul 30, 2021 | COO, GENERAL COUNSEL &CORP SEC |
| ELOX | Eloxx Pharmaceuticals, Inc. | May 25, 2021 | 3 | -$2.55K | 4 | May 26, 2021 | COO, GENERAL COUNSEL &CORP SEC |